![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MYO9A |
Gene summary for MYO9A |
![]() |
Gene information | Species | Human | Gene symbol | MYO9A | Gene ID | 4649 |
Gene name | myosin IXA | |
Gene Alias | CMS24 | |
Cytomap | 15q23 | |
Gene Type | protein-coding | GO ID | GO:0000902 | UniProtAcc | B2RTY4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4649 | MYO9A | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.30e-26 | -7.74e-01 | 0.0155 |
4649 | MYO9A | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.62e-07 | -6.48e-01 | -0.1808 |
4649 | MYO9A | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.04e-07 | -1.08e+00 | 0.0216 |
4649 | MYO9A | HTA11_3361_2000001011 | Human | Colorectum | AD | 7.02e-11 | -8.07e-01 | -0.1207 |
4649 | MYO9A | HTA11_696_2000001011 | Human | Colorectum | AD | 7.50e-16 | -5.75e-01 | -0.1464 |
4649 | MYO9A | HTA11_866_2000001011 | Human | Colorectum | AD | 1.35e-03 | -3.69e-01 | -0.1001 |
4649 | MYO9A | HTA11_2992_2000001011 | Human | Colorectum | SER | 2.88e-03 | -7.24e-01 | -0.1706 |
4649 | MYO9A | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.56e-04 | -7.06e-01 | -0.2061 |
4649 | MYO9A | HTA11_5216_2000001011 | Human | Colorectum | SER | 1.74e-02 | -7.57e-01 | -0.1462 |
4649 | MYO9A | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.87e-04 | -6.49e-01 | -0.0179 |
4649 | MYO9A | HTA11_866_3004761011 | Human | Colorectum | AD | 5.01e-22 | -8.06e-01 | 0.096 |
4649 | MYO9A | HTA11_4255_2000001011 | Human | Colorectum | SER | 4.14e-03 | -6.32e-01 | 0.0446 |
4649 | MYO9A | HTA11_8622_2000001021 | Human | Colorectum | SER | 6.02e-05 | -8.00e-01 | 0.0528 |
4649 | MYO9A | HTA11_10711_2000001011 | Human | Colorectum | AD | 3.90e-09 | -6.62e-01 | 0.0338 |
4649 | MYO9A | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.37e-18 | -6.00e-01 | 0.0674 |
4649 | MYO9A | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.27e-04 | -5.61e-01 | 0.0588 |
4649 | MYO9A | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.46e-37 | -7.27e-01 | 0.294 |
4649 | MYO9A | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.81e-37 | -8.11e-01 | 0.3859 |
4649 | MYO9A | HTA11_99999973899_84307 | Human | Colorectum | MSS | 3.02e-04 | -6.51e-01 | 0.2585 |
4649 | MYO9A | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.11e-47 | -8.79e-01 | 0.3005 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0022604 | Colorectum | AD | regulation of cell morphogenesis | 109/3918 | 309/18723 | 3.08e-09 | 2.07e-07 | 109 |
GO:0034329 | Colorectum | AD | cell junction assembly | 136/3918 | 420/18723 | 2.02e-08 | 1.15e-06 | 136 |
GO:0007163 | Colorectum | AD | establishment or maintenance of cell polarity | 77/3918 | 218/18723 | 5.72e-07 | 2.08e-05 | 77 |
GO:0043087 | Colorectum | AD | regulation of GTPase activity | 110/3918 | 348/18723 | 1.64e-06 | 5.03e-05 | 110 |
GO:0051056 | Colorectum | AD | regulation of small GTPase mediated signal transduction | 94/3918 | 302/18723 | 1.81e-05 | 3.76e-04 | 94 |
GO:0030010 | Colorectum | AD | establishment of cell polarity | 50/3918 | 143/18723 | 6.90e-05 | 1.11e-03 | 50 |
GO:0045197 | Colorectum | AD | establishment or maintenance of epithelial cell apical/basal polarity | 20/3918 | 44/18723 | 2.26e-04 | 2.94e-03 | 20 |
GO:0035088 | Colorectum | AD | establishment or maintenance of apical/basal cell polarity | 21/3918 | 49/18723 | 4.31e-04 | 4.82e-03 | 21 |
GO:0061245 | Colorectum | AD | establishment or maintenance of bipolar cell polarity | 21/3918 | 49/18723 | 4.31e-04 | 4.82e-03 | 21 |
GO:0043547 | Colorectum | AD | positive regulation of GTPase activity | 75/3918 | 255/18723 | 7.95e-04 | 7.91e-03 | 75 |
GO:0001738 | Colorectum | AD | morphogenesis of a polarized epithelium | 31/3918 | 94/18723 | 4.30e-03 | 2.95e-02 | 31 |
GO:0030859 | Colorectum | AD | polarized epithelial cell differentiation | 11/3918 | 24/18723 | 5.43e-03 | 3.55e-02 | 11 |
GO:0090162 | Colorectum | AD | establishment of epithelial cell polarity | 13/3918 | 31/18723 | 6.53e-03 | 4.06e-02 | 13 |
GO:00226041 | Colorectum | SER | regulation of cell morphogenesis | 89/2897 | 309/18723 | 1.51e-09 | 1.52e-07 | 89 |
GO:00071631 | Colorectum | SER | establishment or maintenance of cell polarity | 60/2897 | 218/18723 | 3.45e-06 | 1.33e-04 | 60 |
GO:00343291 | Colorectum | SER | cell junction assembly | 100/2897 | 420/18723 | 4.23e-06 | 1.61e-04 | 100 |
GO:00451971 | Colorectum | SER | establishment or maintenance of epithelial cell apical/basal polarity | 16/2897 | 44/18723 | 5.64e-04 | 7.83e-03 | 16 |
GO:00430871 | Colorectum | SER | regulation of GTPase activity | 77/2897 | 348/18723 | 5.90e-04 | 8.07e-03 | 77 |
GO:00350881 | Colorectum | SER | establishment or maintenance of apical/basal cell polarity | 17/2897 | 49/18723 | 7.17e-04 | 9.44e-03 | 17 |
GO:00612451 | Colorectum | SER | establishment or maintenance of bipolar cell polarity | 17/2897 | 49/18723 | 7.17e-04 | 9.44e-03 | 17 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa048144 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
hsa0481411 | Endometrium | AEH | Motor proteins | 42/1197 | 193/8465 | 2.41e-03 | 1.42e-02 | 1.04e-02 | 42 |
hsa048142 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
hsa048143 | Endometrium | EEC | Motor proteins | 42/1237 | 193/8465 | 4.43e-03 | 2.39e-02 | 1.78e-02 | 42 |
hsa04814 | Lung | MIAC | Motor proteins | 21/507 | 193/8465 | 5.64e-03 | 3.82e-02 | 2.76e-02 | 21 |
hsa048141 | Lung | MIAC | Motor proteins | 21/507 | 193/8465 | 5.64e-03 | 3.82e-02 | 2.76e-02 | 21 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MYO9A | SNV | Missense_Mutation | c.2798T>C | p.Leu933Pro | p.L933P | B2RTY4 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-B7-5818-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
MYO9A | SNV | Missense_Mutation | rs751012778 | c.5824C>T | p.Arg1942Cys | p.R1942C | B2RTY4 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-BR-4292-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MYO9A | SNV | Missense_Mutation | rs201961799 | c.3366N>G | p.Ile1122Met | p.I1122M | B2RTY4 | protein_coding | deleterious(0.02) | probably_damaging(0.972) | TCGA-BR-4361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MYO9A | SNV | Missense_Mutation | rs761456336 | c.1538N>A | p.Arg513Gln | p.R513Q | B2RTY4 | protein_coding | tolerated(0.1) | possibly_damaging(0.564) | TCGA-BR-6452-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MYO9A | SNV | Missense_Mutation | c.1196T>G | p.Phe399Cys | p.F399C | B2RTY4 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BR-7901-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
MYO9A | SNV | Missense_Mutation | c.4403N>A | p.Cys1468Tyr | p.C1468Y | B2RTY4 | protein_coding | tolerated_low_confidence(1) | benign(0) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
MYO9A | SNV | Missense_Mutation | c.2218N>C | p.Ser740Arg | p.S740R | B2RTY4 | protein_coding | tolerated(0.05) | benign(0.312) | TCGA-BR-8687-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
MYO9A | SNV | Missense_Mutation | c.409N>T | p.Arg137Trp | p.R137W | B2RTY4 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-CD-5813-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
MYO9A | SNV | Missense_Mutation | c.803N>C | p.Val268Ala | p.V268A | B2RTY4 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-CG-4305-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | CR | |
MYO9A | SNV | Missense_Mutation | novel | c.7427N>A | p.Gly2476Asp | p.G2476D | B2RTY4 | protein_coding | tolerated_low_confidence(0.2) | benign(0.038) | TCGA-CG-4460-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | capecitabine | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |